The audit of Dr. Reddy's Laboratories Ltd's API Manufacturing Plant 2 at Bollaram, Hyderabad by the US FDA, has been completed today. US FDA has issued a Form 483 with 5 observations and the company has said that it will address them comprehensively within the stipulated timeline.
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.2652.15 as compared to the previous close of Rs. 2583.95. The total number of shares traded during the day was 19083 in over 1394 trades.
The stock hit an intraday high of Rs. 2660 and intraday low of 2586.65. The net turnover during the day was Rs. 50410211.